PolyMedica Mourns Passing of Chairman of Board
18 Juillet 2007 - 10:05PM
Business Wire
PolyMedica Corporation (NASDAQ: PLMD) today announced that Thomas
O. Pyle, Chairman of the Board of Directors for PolyMedica, passed
away this morning, following a long illness. The Company also
announced that James J. Mahoney, Jr., currently a director of
PolyMedica, has been named Chairman of the Board. Mr. Pyle joined
PolyMedica�s Board of Directors in May 2004 and was named Chairman
of the Board in September 2005. Mr. Pyle�s 30-year career in the
healthcare field includes serving as Chief Executive Officer of
MetLife HealthCare, where he initiated the combination of the
MetLife insurance business with that of Travelers, creating METRA,
then the largest company in healthcare, and Chief Executive Officer
of Harvard Community Health Plan (now Harvard Pilgrim Healthcare)
where he oversaw the Company�s growth to one of the nation�s
largest non-profit healthcare organizations. Mr. Pyle also served
as a director of numerous public companies and sat on the Boards of
both private and non-profit groups. In addition, he was the
founding chairman of Controlled Risk Insurance Co., the malpractice
insurance company that insures all of the Harvard Medical School
faculty and the Harvard-affiliated medical institutions. Mr.
Mahoney joined PolyMedica�s Board in November 2005. Mr. Mahoney
currently serves as President and Advisor of the Mahoney Group, a
private financial consulting firm that Mr. Mahoney founded in 2004.
Prior to founding the Mahoney Group, he co-founded the venture
capital and equity investment firm HLM Management Company, where he
spent 20 years working with portfolio companies in technology,
healthcare services, medical technology and business services. Mr.
Mahoney�s vast experience includes having served as general partner
for Cowen & Company and as a securities analyst at Keystone
Custodian Funds. Mr. Mahoney began his career in finance at Touche
Ross & Company. He has significant Board experience with public
and private companies and charitable organizations. Commenting on
the announcement, Chief Executive Officer Patrick Ryan said, �We
are deeply saddened by Tom�s death, and we extend our heart felt
sympathies to his family and friends. Tom�s leadership has left an
indelible imprint upon our company and me personally. We will miss
him as both a valuable member of our Board and as a true friend.�
About PolyMedica For more than a decade, PolyMedica Corporation has
been the nation�s largest provider of blood glucose testing
supplies and related services to people with diabetes and today
serves nearly one million active diabetes patients. The Company
also offers a full service pharmacy to meet patients� medication
needs and provides patient education to help its patients better
manage their health conditions. Through proactive patient outreach,
convenient home delivery and administrative support, PolyMedica
makes it simple for patients to obtain the supplies and medications
they need, while encouraging compliance with physicians� orders.
More information about PolyMedica can be found on the Company�s
website at www.polymedica.com.
Polymedica Corp (MM) (NASDAQ:PLMD)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Polymedica Corp (MM) (NASDAQ:PLMD)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Polymedica Corp (MM) (NASDAQ): 0 recent articles
Plus d'articles sur PolyMedica Corporation